Registered number
10255643
JKR Pharma Ltd
Filleted Accounts
31 March 2024
JKR Pharma Ltd
Registered number: 10255643
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 1,354,942 1,411,992
Tangible assets 4 162,970 181,078
1,517,912 1,593,070
Current assets
Stocks 136,890 135,750
Debtors 5 135,938 173,900
Cash at bank and in hand 91,054 84,892
363,882 394,542
Creditors: amounts falling due within one year 6 (564,241) (562,140)
Net current liabilities (200,359) (167,598)
Total assets less current liabilities 1,317,553 1,425,472
Creditors: amounts falling due after more than one year 7 (1,201,448) (1,275,953)
Net assets 116,105 149,519
Capital and reserves
Called up share capital 160 160
Profit and loss account 115,945 149,359
Shareholders' funds 116,105 149,519
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Tusharbhai Harshad Patel
Director
Approved by the board on 8 August 2024
JKR Pharma Ltd
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 10 years
Fixtures, fittings, tools and equipment over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 8 10
3 Intangible fixed assets £
Goodwill:
Cost
At 1 April 2023 1,711,506
At 31 March 2024 1,711,506
Amortisation
At 1 April 2023 299,514
Provided during the year 57,050
At 31 March 2024 356,564
Net book value
At 31 March 2024 1,354,942
At 31 March 2023 1,411,992
Goodwill is being written off in equal annual instalments over its estimated economic life.
4 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2023 200,707
At 31 March 2024 200,707
Depreciation
At 1 April 2023 19,629
Charge for the year 18,108
At 31 March 2024 37,737
Net book value
At 31 March 2024 162,970
At 31 March 2023 181,078
5 Debtors 2024 2023
£ £
Trade debtors 106,746 111,570
Other debtors 15,250 15,250
VAT recoverable 13,782 13,797
Corporation tax recoverable - 33,123
Calls on Shares 160 160
135,938 173,900
6 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 149,220 149,220
Trade creditors 171,645 208,119
Taxation and social security costs 22,664 3,313
Other creditors 5,712 4,488
Director's account 215,000 197,000
564,241 562,140
7 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 837,448 911,953
Associated company 364,000 364,000
1,201,448 1,275,953
Associated company: A2Z Pharmacy Limited, a company registered in England.
8 Loans 2024 2023
£ £
Creditors include:
Secured bank loans 986,668 1,061,173
The bank loans is a secured by a charge on the company`s assets. The directors have also provided a guarantee limited to £400,000.
9 Other information
JKR Pharma Ltd is a private company limited by shares and incorporated in England. Its registered office is:
5 High Road
Woodgren
London
N22 6BH
JKR Pharma Ltd 10255643 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts October 2023 release 2 Mr Tusharbhai Harshad Patel No description of principal activity 10255643 2022-04-01 2023-03-31 10255643 core:WithinOneYear 2023-03-31 10255643 core:AfterOneYear 2023-03-31 10255643 core:ShareCapital 2023-03-31 10255643 core:RetainedEarningsAccumulatedLosses 2023-03-31 10255643 2023-04-01 2024-03-31 10255643 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10255643 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10255643 bus:Director40 2023-04-01 2024-03-31 10255643 1 2023-04-01 2024-03-31 10255643 2 2023-04-01 2024-03-31 10255643 core:Goodwill 2023-04-01 2024-03-31 10255643 core:PlantMachinery 2023-04-01 2024-03-31 10255643 countries:England 2023-04-01 2024-03-31 10255643 bus:FRS102 2023-04-01 2024-03-31 10255643 bus:FullAccounts 2023-04-01 2024-03-31 10255643 2024-03-31 10255643 core:WithinOneYear 2024-03-31 10255643 core:AfterOneYear 2024-03-31 10255643 core:ShareCapital 2024-03-31 10255643 core:RetainedEarningsAccumulatedLosses 2024-03-31 10255643 core:Goodwill 2024-03-31 10255643 core:PlantMachinery 2024-03-31 10255643 2023-03-31 10255643 core:Goodwill 2023-03-31 10255643 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure